Mean visual acuity improved from 1.29 ± 0.66 (logMAR values) at baseline to 0.73 ± 0.56 (p<0.001) at the 6-month follow-up, foveal thickness improved from 414.96 ± 136.92 microns to 273.01 ± 60.83 microns (p<0.001) at the 6 months follow-up, with no complications in the eyes and body.